| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GCR-H82E4 | Human | Biotinylated Human G-CSF R / CD114 Protein, Avitag™,His Tag (MALS verified) |  |
|
|
| GCR-H5223 | Human | Human G-CSF R / CD114 Protein, His Tag |  |
|
|
| GCR-H5250 | Human | Human G-CSF R / CD114 Protein, Fc Tag |  |
|
|
Immobilized ActiveMax® Human G-CSF, Tag Free (Cat. No. GCF-H5214) at 2 μg/mL (100 μL/well) can bind Human G-CSF R, His Tag (Cat. No. GCR-H5223) with a linear range of 0.01-0.313 μg/mL (QC tested).
The purity of Biotinylated Human G-CSF R, Avitag,His Tag (Cat. No. GCR-H82E4) is more than 85% and the molecular weight of this protein is around 148-184 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Filgrastim biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals Ltd | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Eurofarma) | Approved | Eurofarma | Granulen | Brazil | Neutropenia | Eurofarma | 2012-01-01 | Neutropenia | Details | |
| Recombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group Holding Co Ltd | 里亚金, Li Ya Jin | Mainland China | Neutropenia | Harbin Pharmaceutical Group Holding Co Ltd | 2000-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Apotex/Intas) | Approved | Apotex, Intas Biopharmaceuticals | Neukine, Grastofil, SciLocyte | EU | Neutropenia | Accord Healthcare Slu | 2004-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Claris Lifesciences) | Approved | Claris Lifesciences | Fegrast | India | Neutropenia | Claris Lifesciences | 2012-01-01 | Neutropenia | Details | |
| Empegfilgrastim | BCD-017 | Approved | Biocad | Extimia | Neutropenia | Details | ||||
| Filgrastim biosimilar (Chengdu Institute of Biological Products) | Approved | 保力津, Baolijin | Mainland China | Neutropenia | Chengdu Institute Of Biological Products Co Ltd | 2001-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Pharmapark) | Approved | Pharmapark | Neutropenia | Pharmapark | 2008-01-01 | Neutropenia | Details | |||
| Filgrastim biosimilar (Qilu Pharmaceutical) | Approved | Qilu Pharmaceutical Co Ltd | 瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Siam Bioscience) | Approved | Siam Bioscience | Neutropenia | Details | ||||||
| Recombinant human granulocyte colony-stimulating factor (Shanghai Sunway Biotech) | Approved | Shanghai Sunway Bio Co Ltd | 赛格力, SunGran | Mainland China | Neutropenia | Shanghai Sunway Bio Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering) | Approved | Hangzhou Jiuyuan Gene Engineering Co Ltd | 吉粒芬, Jilifen | Mainland China | Neutropenia | Hangzhou Jiuyuan Gene Engineering Co Ltd | 1998-04-01 | Neutropenia | Details | |
| Filgrastim biosimilar (GeneScience Pharmaceuticals) | Approved | Changchun Genescience Pharmaceutical Co Ltd | Scimax, 金磊赛强 | Mainland China | Neutropenia | Changchun Genescience Pharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Lupin) | Approved | Rubin Ltd | Lupifil | India | Neutropenia | Rubin Ltd | 2016-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Landsteiner) | Approved | Landsteiner Scientific | Biofilgran | Neutropenia | Details | |||||
| Lenograstim biosimilar (Biosidus) | Approved | Biosidus | Lenobio, Leumostin, Lenograstim Biosidus | Neutropenia | Details | |||||
| Filgrastim biosimilar (Neiss Labs) | Approved | Neiss Labs | Nisgras | India | Neutropenia | Neiss Labs | 2012-08-01 | Neutropenia | Details | |
| Filgrastim biosimilar(Pooyesh Darou Pharmaceuticals) | G-CSF | Approved | Pooyesh Darou | PD-grastim | Iran | Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Lymphoma; Neutropenia | Pooyesh Darou | 2012-09-01 | Neutropenia; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Lymphoma | Details |
| Filgrastim biosimilar (Biosidus) | Approved | Biosidus | Neutromax, Granulostim | Neutropenia | Details | |||||
| Filgrastim biosimilar (PanPharmaceuticals) | Approved | Harvest Moon | India | Febrile Neutropenia | null | 2012-01-01 | Febrile Neutropenia | Details | ||
| Molgramostim biosimilar (RAS Lifesciences) | Approved | Biomerieux | India | Neutropenia | Biomerieux | 2012-10-01 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Lupin) | Approved | Lupin | Lupifil-P | India | Neutropenia | Rubin Ltd | 2016-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Xiamen Amoytop Biotech) | Approved | Xiamen Amoytop Biotech Co Ltd | 特尔津, Topneuter | Mainland China | Neutropenia | Xiamen Amoytop Biotech Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (CIGB/Heber Biotec) | Approved | Center For Genetic Engineering And Biotechnology, Heber Biotec | Hebervital | Neutropenia | null | 2009-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (RPG Life Sciences) | Approved | Rpg Life Sciences | Frastim | India | Neutropenia | Rpg Life Sciences | 2012-08-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (AryaTinaGene) | Approved | Aryatinagene Biopharmaceuticals | Tinapeg | Febrile Neutropenia | Details | |||||
| Pegfilgrastim biosimilar (CinnaGen) | Approved | Cinnagen | PegaGen | Neutropenia | Details | |||||
| Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences) | Approved | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 吉洛因 | Mainland China | Myelodysplastic Syndromes; Leukopenia | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 2001-01-01 | Myelodysplastic Syndromes; Leukopenia | Details | |
| Filgrastim biosimilar (Unilab) | Approved | Unilab | Neocyte | Neutropenia | Details | |||||
| Filgrastim biosimilar (Biolotus Biotech) | Approved | Biolotus | Kymun-CSF | Brazil | Neutropenia | Biolotus | 2016-06-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Cinfa Biotech) | B-12019 | Approved | Cinfa Biotech | Pelmeg | EU | Neutropenia | Mundipharma Corporation (Ireland) Ltd | 2018-11-20 | Neutropenia | Details |
| Filgrastim biosimilar (NCPC GeneTech Biotechnology Development) | Approved | North China Pharmaceutical Company Ltd | GeSysin | Mainland China | Neutropenia | North China Pharmaceutical Company Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | ReliGrast | India | Neutropenia | Reliance Life Sciences | 2008-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Probiomed) | Approved | Probiomed | Filatil | Mexico | Neutropenia | Probiomed | 2006-03-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Laboratorio Varifarma) | Approved | Laboratorio Varifarma | Neutrofil | Neutropenia | Details | |||||
| Filgrastim biosimilar (PT Kalbe) | Approved | Kalbe Farma | India | Neutropenia | Kalbe Farma | 2012-08-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Blau Pharmaceuticals) | Approved | Blau Pharmaceuticals | Brazil | Neutropenia | Blau Pharmaceuticals | 2012-10-01 | Neutropenia | Details | ||
| Nartograstim | KW-2228; PE-2601; ND-28 | Approved | Kyowa Hakko Kirin | Neu-up | Japan | Neutropenia | Kyowa Hakko Kirin | 1994-04-01 | Neutropenia | Details |
| Filgrastim biosimilar (Sedico) | Approved | Sedico | Neutropenia | Details | ||||||
| Recombinant human granulocyte colony-stimulating factor (Shandong Kexing Bioproducts Co Ltd) | Approved | Shandong Kexing Bio-Products Co Ltd | 白特喜 | Mainland China | Neutropenia | Shandong Kexing Bio-Products Co Ltd | 2001-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare | Accofil | EU | Neutropenia | Accord Healthcare Slu | 2014-09-17 | Neutropenia | Details | |
| Filgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | United States | Neutropenia | Amgen Inc | 1991-02-20 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Qilu Pharmaceuticals) | PEG-rhG-CSF (Qilu Pharmaceuticals) | Approved | Qilu Pharmaceutical Co Ltd | 新瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 2015-08-08 | Neutropenia | Details |
| Filgrastim biosimilar (Shandong Quangang Pharmaceutical) | Approved | Shandong Quangang Pharmaceutical Co Ltd | 泉升, Quan Sheng | Mainland China | Neutropenia | Shandong Quangang Pharmaceutical Co Ltd | 2002-04-16 | Neutropenia | Details | |
| Filgrastim biosimilar (Sudershan Biotech) | Approved | Sudershan Biotech Ltd | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Center of Molecular Immunology) | Approved | Center Of Molecular Immunology | ior-LeukoCIM | Cuba | Neutropenia | Center Of Molecular Immunology | 2016-01-14 | Neutropenia | Details | |
| Recombinant human granulocyte stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津恤力, GeneLeukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2000-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (AqVida) | Approved | Aqvida | Leucita | Chile | Neutropenia | Aqvida | 2008-05-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium) | Approved | Cjsc Generium, Pharmstandard, Masterclone | Neipomax, Neupomax | Neutropenia | null | 2008-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Veropharm) | Approved | Abbott Laoratories | Mielastra | Neutropenia | Details | |||||
| Pegfilgrastim biosimilar (Dr Reddy's Laboratories) | DRL_PG | Approved | Peg-grafeel | India | Neutropenia | Dr. Reddy’S Laboratories Ltd | 2011-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Elea) | Approved | Elea | Neutropenia | Details | ||||||
| Filgrastim biosimilar (RAS Lifesciences) | Approved | Ras Lifesciences | India | Neutropenia | Ras Lifesciences | 2012-01-01 | Neutropenia | Details | ||
| Recombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical) | Approved | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 欣粒生, Xin Lisheng | Mainland China | Neutropenia | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 2002-06-17 | Neutropenia | Details | |
| Filgrastim biosimilar (Chalver Laboratorios) | Approved | Chalver Laboratorios | Leucosos | Colombia | Neutropenia | Chalver Laboratorios | 2012-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Nanogen) | Approved | Nanogen Biopharmaceutical Co | Ficocyte | Vietnam | Neutropenia | Nanogen Biopharmaceutical Co | 2014-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Apexcela) | SBS-6002; Leuco-Plus-300 | Approved | Apexcela | Neutropenia | Details | |||||
| Filgrastim biosimilar (Laboratorios AC Farma) | Approved | Laboratorios Ac Farma | FGM-Factor | Peru | Neutropenia | Laboratorios Ac Farma | 2012-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science) | GBS-001; FSK-0808 | Approved | Mochida Pharmaceutical Co Ltd, Gene Techno Science, Fuji Pharmaceutical | Japan | Neutropenia | Fuji Pharmaceutical | 2012-11-21 | Neutropenia | Details | |
| Filgrastim biosimilar (Dr Reddy's Laboratories) | Approved | Grafeel | India | Neutropenia | Dr. Reddy’S Laboratories Ltd | 2001-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure | India | Neutropenia | Emcure | 2013-01-01 | Neutropenia | Details | ||
| Recombinant human granulocyte colony-stimulating Factor (Shenzhen Xinpeng Bio-tech) | Approved | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 瑞血新 | Mainland China | Neutropenia | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing Sl Pharmaceutical Co Ltd | 立生素, Li Sheng Su | Mainland China | Neutropenia | Beijing Sl Pharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Biocon) | Approved | Biocon Biopharmaceuticals | Nufil | India | Neutropenia | null | 2008-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (CJ Corp) | Approved | Cj | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar(Shandong New Time Pharmaceutical ) | Approved | Shandong New Time Pharmaceutical Co Ltd | Details | |||||||
| Pegfilgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare | Pelgraz | EU | Neutropenia | Accord Healthcare Slu | 2018-09-21 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Sandoz) | LAEP-2006 | Approved | Clariant Produkte (Schweiz) Ag | Zioxtenzo, Ziextenzo | United States | Febrile Neutropenia | Sandoz Inc | 2018-11-22 | Neutropenia; Febrile Neutropenia | Details |
| Pegfilgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Intas Biopharmaceuticals) | INTP-5 | Approved | Intas Biopharmaceuticals, Apotex | Neupeg, Lapelga, Pegasta | India | Neutropenia | null | 2007-01-01 | Neutropenia | Details |
| Pegfilgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals) | Approved | Harvest Moon | India | Neutropenia | null | 2012-01-01 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Juta Pharma) | Approved | Juta Pharma | Grasustek | EU | Neutropenia | Juta Pharma Gmbh | 2019-04-26 | Neutropenia | Details | |
| Filgrastim biosimilar (Chandra Bhagat Pharma) | Approved | Chandra Bhagat Pharma（Cbc） | Filgen | India | Neoplasms | Chandra Bhagat Pharma（Cbc） | 2012-08-01 | Neoplasms | Details | |
| Filgrastim biosimilar (Fresenius Kabi Oncology) | Approved | Fresenius Kabi Ag | India | Neutropenia | Fresenius Kabi Ag | 2012-08-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Zenotech Laboratories) | Approved | Zenotech Laboratories | Neoplasms; Neutropenia | Zenotech Laboratories | 2006-03-01 | Neutropenia; Neoplasms | Details | |||
| Filgrastim biosimilar (Zuventus Healthcare) | Approved | Zuventus Healthcare | India | Neutropenia | Zuventus Healthcare | 2012-08-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Adello Biologics/KASHIV BIOSCIENCES) | Approved | Adello Biologics | United States | Neutropenia | Kashiv BioSciences LLC | 2022-02-25 | Neutropenia | Details | ||
| Filgrastim biosimilar (Tanvex BioPharma) | TX-01 | Approved | Canada | Febrile Neutropenia | Tanvex Biopharma | 2021-10-17 | Febrile Neutropenia | Details | ||
| Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Beijing Beiyi Union) | Approved | Beijing Beiyi Union Pharmaceutical Co Ltd | 健白 | Mainland China | Neutropenia | Beijing Beiyi Union Pharmaceutical Co Ltd | 2002-05-08 | Neutropenia | Details | |
| Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Foshan Hanyu) | Approved | 格宁 | Mainland China | Neutropenia | Foshan Hanyu Biopharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | ||
| Recombinant human granulocyte macrophage colony stimulating factor (Kyowa Hakko Kirin) | Approved | Ise Plant, Nipro Pharma Corp, Kyowa Hakko Kirin China Pharmaceutical Co Ltd | Details | |||||||
| Recombinant Human Granulocyte Colony-stimulating Factor (Wuzhong Group) | Approved | Suzhou Pharmaceutical Factory | 洁欣, Jiexin | Mainland China | Neutropenia | Suzhou Pharmaceutical Factory | 1999-01-01 | Neutropenia | Details | |
| Pegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津优力, Pegleukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2011-10-21 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Adello Biologics) | TPI-120 | Approved | Adello Biologics | FYLNETRA | United States | Febrile Neutropenia | Kashiv BioSciences LLC | 2022-05-26 | Neutropenia; Febrile Neutropenia | Details |
| Pegfilgrastim biosimilar (Dong-A ST) | DA-3031 | Approved | Dong-A Pharmaceutical Co Ltd | Dulastin | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 2014-01-01 | Neutropenia | Details |
| Lenograstim | rG-CSF | Approved | Chugai Pharmaceutical Co Ltd | 格拉诺赛特, Neutrogin, Granocyte | Mainland China | Neutropenia | null | 1991-10-04 | Neutropenia; Multiple Myeloma; Lymphoma, Non-Hodgkin | Details |
| Lipegfilgrastim | XM-22 | Approved | Teva | Lonquex | EU | Neutropenia | Teva Bv | 2013-07-25 | Neutropenia | Details |
| Filgrastim biosimilar (Hospira) | PLD-108 | Approved | Hospira | Nivestim, Nivestym | EU | Neutropenia | Pfizer Europe Ma Eeig | 2010-06-07 | Neutropenia | Details |
| Pegfilgrastim biosimilar (Fresenius SE) | MSB-11455 | Approved | Merck Serono | Stimufend | EU | Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Fresenius Kabi Deutschland Gmbh | 2022-03-28 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Details |
| Filgrastim biosimilar (Dong-A) | DA-3030 | Approved | Dong-A Pharmaceutical Co Ltd | Leukostim | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 1999-01-01 | Neutropenia | Details |
| Filgrastim | rhGCSF (Amgen/Kyowa Hakko Kirin); r-metHuG-CSF; REC-G-CSF; KRN-8601 | Approved | Amgen Inc, Kyowa Hakko Kirin | 吉粒芬, Gran, Nugraf, Neupogen, Granulokine, 惠尔血, 优保津, 特尔津, 瑞白, 吉赛欣, 津恤力 | Mainland China | Neutropenia | Kyowa Hakko Kirin | 1991-10-04 | Neutropenia | Details |
| Pegfilgrastim biosimilar (Coherus BioSciences) | CHS-1701 | Approved | Coherus Biosciences Inc | Udenyca | United States | Febrile Neutropenia | Coherus Biosciences Inc | 2018-09-21 | Neutropenia; Febrile Neutropenia | Details |
| Pegfilgrastim | KRN-125; R-1471; SD-01; SD/01 | Approved | Amgen Inc, Kyowa Hakko Kirin Co Ltd | G-Lasta, Ristempa, Neulasta, Neulastim | Japan | Neutropenia | Kyowa Hakko Kirin Co Ltd | 2002-01-31 | Neutropenia | Details |
| GCPGC | MG-1107 | Approved | Korean Green Cross Corp | Neulapeg | South Korea | Neutropenia | Korean Green Cross Corp | 2014-01-01 | Solid tumours; Neutropenia | Details |
| Mecapegfilgrastim (Hengrui) | HHPG-19K | Approved | Jiangsu Hengrui Medicine Co Ltd | 艾多 | Mainland China | Neutropenia | Jiangsu Hengrui Medicine Co Ltd | 2018-05-08 | Neutropenia; Lymphoma | Details |
| Pegfilgrastim biosimilar (Biocon/Mylan) | MYL-1401H | Approved | Biocon | Fulphila | EU | Neutropenia | Viatris Ltd | 2018-06-04 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Lymphoma, Large B-Cell, Diffuse; Urinary Bladder Neoplasms; Breast Neoplasms; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Febrile Neutropenia | Details |
| Pegfilgrastim biosimilar (Hospira) | HSP-130 | Approved | Pfizer Pharmaceuticals Ltd (China), Hospira | Nyvepria | EU | Neutropenia | Pfizer Europe Ma Eeig | 2020-06-10 | Neutropenia; Lymphoma, Large B-Cell, Diffuse; Urinary Bladder Neoplasms; Breast Neoplasms; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Febrile Neutropenia | Details |
| Filgrastim biosimilar (Sandoz) | EP-2006 | Approved | Sandoz | Zarxio, Zarzio | United States | Neutropenia | Sandoz Inc | 2009-02-06 | Neutropenia; Breast Neoplasms | Details |
| Tbo-filgrastim | XM-02; TKN-732 | Approved | Teva | Granix, Biograstim, Tevagrastim | Japan | Neutropenia | Nippon Kayaku, Teva Pharmaceutical Industries Ltd | 2008-09-15 | Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hematologic Neoplasms; Lymphoma, B-Cell; Neutropenia; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Plasmablastic Lymphoma; Lymphoma, Non-Hodgkin | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Filgrastim biosimilar (Biogenomics) | Phase 1 Clinical | Biogenomics | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Bio-Ker) | Phase 1 Clinical | Bio-Ker | Neutropenia | Details | |
| Pegfilgrastim ANF | PEG-G-CSF-ANF | Phase 2 Clinical | Prolong Pharmaceuticals | Neutropenia | Details |
| Pegfilgrastim biosimilar (Affiliated Hospital of North Sichuan Medical College) | Clinical | Affiliated Hospital Of North Sichuan Medical College | Neutropenia | Details | |
| PEGylated G-CSF | BBT-015 | Phase 1 Clinical | Bolder Biotechnology | Neutropenia; Acute Radiation Syndrome | Details |
| Filgrastim biosimilar (Virchow Group) | Neutrogen | Phase 3 Clinical | Virchow Group | Neutropenia | Details |
| Filgrastim biosimilar (MenoGenix) | MNGX-100 | Phase 1 Clinical | Menogenix | Menopausal symptoms | Details |
| Filgrastim biosimilar (Bio-Ker) | BK-0023 | Phase 3 Clinical | Bio-Ker | Neutropenia | Details |
| Pegfilgrastim biosimilar (Reliance Life Sciences) | R-TPR-029 | Phase 3 Clinical | Reliance Life Sciences | Neutropenia | Details |
| JZB-27 | JZB-27 | Phase 2 Clinical | Shanghai Jingze Biotechnology Co Ltd, Hunan Jingfeng Pharmaceutical Co Ltd | Neutropenia | Details |
| Pegfilgrastim biosimilar (Beijing SL Pharmaceutical) | Clinical | Beijing Sl Pharmaceutical Co Ltd | Neutropenia | Details | |
| Albumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech) | SFR-9314; rHSA/GCSF | Phase 2 Clinical | Beijing Meifuyuan Biomedical Technology Co Ltd, Tianjin Puying Biotechnology Co Ltd | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Agranulocytosis | Details |
| QL-0605 | PEG-rhG-CSF | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Details | |
| Pegfilgrastim biosimilar (Megalabs) | Details | ||||
| Y-branched pegylated recombinant human granulocyte colony stimulating factor | YPEG-rhG-CSF | Phase 3 Clinical | Xiamen Amoytop Biotech Co Ltd | Neutropenia; Neoplasms | Details |
| 8MW-0511 | GW-003; 8MW-0511; 8MW0511; MW-05 | Phase 3 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Leukopenia | Details |
| Eflapegrastim | HNK-460; SPI-2012; HM-10460A; LAPS-GCSF | Hanmi Pharmaceutical Co Ltd | Details | ||
| SBC-014 | AES-014; AVI-014; SBC-014 | Alexion Pharmaceuticals Inc | Details | ||
| Pegylated recombinant human granulocyte colony stimulating factor (Hangzhou Jiuyuan Gene) | Phase 3 Clinical | Hangzhou Jiuyuan Gene Engineering Co Ltd | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical) | Phase 1 Clinical | Jiangsu Aosaikang Pharmaceutical Co Ltd | Solid tumours | Details | |
| Granulocyte colony-stimulating factor (Shire) | Phase 3 Clinical | Shire Pharmaceuticals | Thalassemia; Myelodysplastic Syndromes; Anemia, Diamond-Blackfan; Shwachman-Diamond Syndrome; Leukemia, Myeloid, Acute; Kostmann Syndrome; Anemia, Sickle Cell | Details | |
| Anumigilimab | CSL-324 | Phase 1 Clinical | Csl Ltd, Murigen | Coronavirus Disease 2019 (COVID-19); Psoriasis; Hidradenitis Suppurativa | Details |
This web search service is supported by Google Inc.
A-Z
FLAG
Star Staining
ViruStop
Aneuro
ComboX
ActiveMax
GENPower
ClinMax 
